Cyclacel Pharmaceuticals Inc (CYCC)
1.99
+0.16
(+8.74%)
USD |
NASDAQ |
Apr 24, 11:35
Cyclacel Pharmaceuticals Total Return Level: 1.83 for April 23, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 23, 2024 | 1.83 |
April 22, 2024 | 1.75 |
April 19, 2024 | 1.78 |
April 18, 2024 | 1.85 |
April 17, 2024 | 1.96 |
April 16, 2024 | 1.67 |
April 15, 2024 | 1.57 |
April 12, 2024 | 1.76 |
April 11, 2024 | 1.94 |
April 10, 2024 | 2.05 |
April 09, 2024 | 2.11 |
April 08, 2024 | 2.11 |
April 05, 2024 | 2.10 |
April 04, 2024 | 2.193 |
April 03, 2024 | 2.19 |
April 02, 2024 | 2.12 |
April 01, 2024 | 2.05 |
March 28, 2024 | 2.110 |
March 27, 2024 | 1.96 |
March 26, 2024 | 1.92 |
March 25, 2024 | 2.14 |
March 22, 2024 | 2.188 |
March 21, 2024 | 2.18 |
March 20, 2024 | 2.250 |
March 19, 2024 | 2.35 |
Date | Value |
---|---|
March 18, 2024 | 2.51 |
March 15, 2024 | 2.43 |
March 14, 2024 | 2.496 |
March 13, 2024 | 2.59 |
March 12, 2024 | 2.481 |
March 11, 2024 | 2.52 |
March 08, 2024 | 2.64 |
March 07, 2024 | 2.49 |
March 06, 2024 | 2.37 |
March 05, 2024 | 2.59 |
March 04, 2024 | 2.70 |
March 01, 2024 | 2.90 |
February 29, 2024 | 2.56 |
February 28, 2024 | 2.68 |
February 27, 2024 | 2.72 |
February 26, 2024 | 2.80 |
February 23, 2024 | 2.65 |
February 22, 2024 | 2.63 |
February 21, 2024 | 2.715 |
February 20, 2024 | 2.93 |
February 16, 2024 | 2.969 |
February 15, 2024 | 2.665 |
February 14, 2024 | 2.571 |
February 13, 2024 | 2.49 |
February 12, 2024 | 2.460 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.57
Minimum
Apr 15 2024
274.50
Maximum
Jan 10 2020
66.82
Average
56.10
Median
Sep 18 2020
Total Return Level Benchmarks
Corvus Pharmaceuticals Inc | 1.53 |
Oragenics Inc | 1.09 |
Relmada Therapeutics Inc | 3.91 |
Alpine Immune Sciences Inc | 64.53 |
MAIA Biotechnology Inc | 2.46 |